Non Invasive Prenatal Testing Market Outlook:
Non Invasive Prenatal Testing Market size was valued at USD 7.24 billion in 2025 and is set to exceed USD 27.56 billion by 2035, registering over 14.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of non invasive prenatal testing is estimated at USD 8.17 billion.
This non invasive prenatal testing (NIPT) market growth can be attributed to the rise in maternal age, an increase in awareness of genetic disorders, and technological advancements in genomic sequencing. Individuals are looking forward to safer, accurate ways due to which NIPT emerged as a favored choice over the earlier risky invasive detection techniques. Major companies in the NIPT sector are displaying active investments in research and development activities for further improvement in their test capacities and geographic expansion.
One of the most recent advances taken place in the industry is from Invitae Corporation, an announcement in March 2024 stating that its new platform for NIPT, developed to present exhaustive coverage of rare genetic conditions, is expected to have greater accuracy for detecting common trisomy. This is another notable factor that companies are working to be competitive to continue to change to meet the needs of health providers, together with their patients.
The government and other regulatory bodies are also playing their role in boosting the NIPT market growth. There have been updates in the prenatal screening guidelines by many countries. This first-line option of screening is essential for envisaging high-risk pregnancies. For example, the UK National Health Service has been gradually introducing NIPT into its prenatal screening program. This is probably driven by growing attitudes toward NIPT; as per statistics from NHS, in 2023, around 65% of the eligible pregnant population in England had undergone NIPT testing. Moreover, increasing government initiatives to raise awareness about genetic disorders and improvement in access to prenatal care are further expected to drive the non invasive prenatal testing market in the upcoming years.
